Ligand validation:7YFT

IRV: (2~{S})-2-(5-imidazol-1-ylpentanoylamino)-3-phenyl-propanoic acid

IRV is a Ligand Of Interest in 7YFT designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7YFT_IRV_B_504	0%	36%	0.648	0.581	1.48	1.07	2	2	2	0	100%	0.47
7YFT_IRV_A_504	0%	39%	0.697	0.396	1.52	0.86	2	2	4	0	100%	0.62
7YDD_IRV_A_504	45%	29%	0.165	0.896	1.73	1.15	3	4	0	0	100%	0.47
7YDA_IRV_A_502	34%	27%	0.188	0.873	1.52	1.44	2	5	0	0	100%	0.44
7YDC_IRV_B_503	31%	30%	0.185	0.854	1.58	1.22	3	2	2	0	100%	0.39
7YJF_IRV_A_503	29%	25%	0.204	0.86	1.43	1.64	3	7	1	0	100%	0.58
7YDB_IRV_B_504	27%	37%	0.174	0.818	1.5	0.98	3	1	0	0	100%	0.58
7YJH_IRV_B_503	18%	40%	0.218	0.803	1.51	0.86	3	1	0	0	100%	0.45

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.